Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy

BACKGROUND: A 2-year roadmap study was conducted to evaluate the efficacy and safety of tenofovir intensification at Week 24 in patients with chronic hepatitis B (CHB) receiving telbivudine. SCOPE: A prospective multicenter study was conducted in treatment-naive patients with hepatitis B e antigen (...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Drugs Context
Main Authors: Piratvisuth, Teerha, Komolmit, Piyawat, Chan, Henry LY, Tanwandee, Tawesak, Sukeepaisarnjaroen, Wattana, Pessoa, Mário G, Fassio, Eduardo, Ono, Suzane K, Bessone, Fernando, Daruich, Jorge, Zeuzem, Stefan, Manns, Michael, Uddin, Alkaz, Dong, Yuhong, Trylesinski, Aldo
פורמט: Artigo
שפה:Inglês
יצא לאור: Just Medical Media Limited 2016
נושאים:
Brief Report
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4924977/
https://ncbi.nlm.nih.gov/pubmed/27403192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212294
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים